Total Payments
$2,883
2023 Payments
$184.05
Companies
24
Transactions
165
Medicare Patients
747
Medicare Billing
$143,049
Payment Breakdown by Category
Food & Beverage$2,883 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,883 | 165 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $423.50 | 22 | $0 (2022) |
| Allergan, Inc. | $389.06 | 22 | $0 (2020) |
| AbbVie Inc. | $346.77 | 20 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $336.19 | 20 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $244.38 | 15 | $0 (2023) |
| Shire North American Group Inc | $173.91 | 11 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $143.96 | 8 | $0 (2022) |
| ITI, Inc. | $108.79 | 7 | $0 (2022) |
| Lundbeck LLC | $101.42 | 6 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $96.07 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $184.05 | 10 | AbbVie Inc. ($74.11) |
| 2022 | $393.60 | 21 | ABBVIE INC. ($139.91) |
| 2021 | $473.64 | 29 | AbbVie Inc. ($132.75) |
| 2020 | $357.58 | 22 | Takeda Pharmaceuticals U.S.A., Inc. ($118.76) |
| 2019 | $407.90 | 23 | Neurocrine Biosciences, Inc. ($70.73) |
| 2018 | $468.03 | 28 | Takeda Pharmaceuticals U.S.A., Inc. ($84.73) |
| 2017 | $597.87 | 32 | Allergan Inc. ($227.96) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Central Nervous System | ||||||
| 04/24/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/03/2023 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/28/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Central Nervous System | ||||||
| 03/20/2023 | Noven Therapeutics, LLC | Secuado (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: CNS Psychiatry | ||||||
| 03/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Central Nervous System | ||||||
| 11/14/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Central Nervous System | ||||||
| 11/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/26/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Neuroscience | ||||||
| 08/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Neuroscience | ||||||
| 05/23/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/16/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Neuroscience | ||||||
| 04/04/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 134 | 408 | $92,465 | $28,488 |
| 2022 | 4 | 179 | 531 | $107,157 | $40,357 |
| 2021 | 4 | 206 | 553 | $97,373 | $40,084 |
| 2020 | 5 | 228 | 578 | $94,856 | $34,120 |
Total Patients
747
Total Services
2,070
Medicare Billing
$143,049
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 196 | $54,837 | $16,997 | 31.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 43 | 148 | $25,012 | $7,404 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 64 | $12,616 | $4,087 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 254 | $59,175 | $22,744 | 38.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 57 | 192 | $30,368 | $10,077 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 60 | $9,766 | $4,180 | 42.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 25 | $7,848 | $3,356 | 42.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 214 | $46,010 | $21,152 | 46.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 57 | 209 | $31,977 | $10,861 | 34.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 84 | $12,348 | $5,412 | 43.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 31 | 46 | $7,038 | $2,658 | 37.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 76 | 195 | $28,665 | $10,032 | 35.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 130 | $27,950 | $9,999 | 35.8% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 62 | 186 | $28,458 | $9,666 | 34.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 19 | 30 | $5,334 | $2,441 | 45.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 22 | 37 | $4,449 | $1,983 | 44.6% |
About Dr. Catharine Wolfe, MD
Dr. Catharine Wolfe, MD is a Psychiatry healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2011. The National Provider Identifier (NPI) number assigned to this provider is 1346530359.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catharine Wolfe, MD has received a total of $2,883 in payments from pharmaceutical and medical device companies, with $184.05 received in 2023. These payments were reported across 165 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,883).
As a Medicare-enrolled provider, Wolfe has provided services to 747 Medicare beneficiaries, totaling 2,070 services with total Medicare billing of $143,049. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Student in an Organized Health Care Education/Training Program, Psychiatry
- Location Marietta, GA
- Active Since 04/11/2011
- Last Updated 06/25/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1346530359
Products in Payments
- VRAYLAR (Drug) $735.83
- TRINTELLIX (Drug) $355.54
- AUSTEDO (Drug) $294.18
- REXULTI (Drug) $246.10
- Trintellix (Drug) $130.24
- CAPLYTA (Drug) $108.79
- VYVANSE (Drug) $96.21
- LATUDA (Drug) $96.07
- Dayvigo (Drug) $93.14
- INVEGA SUSTENNA (Drug) $84.92
- MYDAYIS (Drug) $77.70
- INGREZZA (Drug) $70.73
- Fanapt (Drug) $63.73
- AZSTARYS (Drug) $63.13
- SPRAVATO (Drug) $59.04
- Adzenys XR-ODT (Drug) $50.40
- Austedo XR (Drug) $26.54
- ADHANSIA XR (Drug) $20.92
- JORNAY PM (Drug) $20.91
- Evekeo (Drug) $20.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Marietta
Dr. Michael Banov, Md, MD
Psychiatry — Payments: $1.2M
Psychiatry $1.2M
Dr. Michael Unger, M.d, M.D
Psychiatry — Payments: $83,233
Psychiatry $83,233
Dr. Amy Holland, M.d, M.D
Psychiatry — Payments: $14,581
Psychiatry $14,581
Mohamedlatif Saiyad, Md, MD
Psychiatry — Payments: $4,783
Psychiatry $4,783
Dr. Cliff Lin, M.d, M.D
Psychiatry — Payments: $3,680
Psychiatry $3,680
Dr. Rohit Khanna, M.d, M.D
Psychiatry — Payments: $2,670
Psychiatry $2,670